Abstract:Purpose The present study was designed to determine pharmacological and biochemical properties of 2-methoxyantimycin A analogs (OMe-A1, OMe-A2, OMe-A3, and OMe-A5), which are novel antitumor compounds, and provide a basis for future pharmaceutical development, preclinical evaluation, and clinical trials. Methods A high-performance liquid chromatography (HPLC) method was established and employed to assess the biostability of these analogs and to determine their pharmacokinetic properties in mice and rats. Results In vitro biostability of the 2-methoxyantimycin analogs was esterase-dependent, compound-dependent, and species-dependent. In the absence of esterase inhibitors, all of the analogs were relatively unstable. Stability was greater, however, in human and dog plasma than in rat and mouse plasma. In the presence of esterase inhibitors, OMe-A1 was stable at 37°C for 60 min in mouse and rat plasma, moderately stable in human plasma, and unstable in dog plasma. OMe-A2 was generally stable in all types of plasma. OMe-A3 was stable in dog and rat plasma, but not in human or mouse plasma. OMe-A5 was stable in human and dog plasma, but not in mouse or rat plasma. Each of these analogs was highly bound to plasma proteins. Of S9 fractions from four species, human S9 was least efficient in metabolizing OMe-A3. Following an intravenous dose of OMe-A1 in mice, plasma levels decreased rapidly, with an initial half-life of 2.7 min and a terminal half life of 34 min. Following an intraperitoneal dose in mice, plasma levels decreased less rapidly with a terminal half-life of 215 min. Following an intravenous dose of OMe-A1 or OMe-A3 in rats, plasma levels decreased more rapidly with initial half-lives of about 1.0 min. At an equivalent dose, OMe-A3 had a faster clearance than OMe-A1. Conclusions For 2-methoxyantimycin A analogs, species differences in biostability, metabolism, and pharmacokinetics may be pertinent in assessing their pharmacological and toxicological profiles and antitumor activity in humans.

Inhibition of Human Cancer Cell Growth by Analogues of Antimycin A.

Antimycin A shows selective antiproliferation to oral cancer cells by oxidative stress‐mediated apoptosis and DNA damage

A Novel Antimycin Analogue Antimycin A2c, Derived from Marine Streptomyces Sp., Suppresses HeLa Cells Via Disrupting Mitochondrial Function and Depleting HPV Oncoproteins E6/E7.

Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents

Synthesis and Biological Evaluation of Novel Anthranilamide Derivatives As Anticancer Agents

A Novel Sulfonamide Agent, MPSP-001, Exhibits Potent Activity Against Human Cancer Cells in Vitro Through Disruption of Microtubule

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Investigation of the antimicrobial and anticancer activity of aminonaphthoquinones

The Natural Product CCR5 Antagonist Anibamine and Its Analogs As Anti-Prostate Cancer Agents

Marine Streptomyces sp. derived antimycin analogues suppress HeLa cells via depletion HPV E6/E7 mediated by ROS-dependent ubiquitin–proteasome system

Synthesis And Anti-Tumor Study Of 3-Aryl-4-Oxo-Thiazolidin-2-Carboxylic Acid Amides

Design and synthesis of aminothiazole-benzazole based amide: antiproliferative, antimigration activity and molecular docking studies

Design,Synthesis and in vitro Antitumor Activity of Novel Actinomycin D Analogs

Amino Acid Conjugates of Aminothiazole and Aminopyridine As Potential Anticancer Agents: Synthesis, Molecular Docking and in Vitro Evaluation.

In Vitro and in Vivo Antitumor Effects of Novel Actinomycin D Analogs with Amino Acid Substituted in the Cyclic Depsipeptides.

Selective Functionalization of Antimycin A Through an N-Transacylation Reaction.

Synthesis and Cytotoxicity Evaluation of 2-(4-((1,3-Dioxoisoindolin-2-yl)methyl)phenyl)-N-phenyl-thiazole-4-carboxamide Derivatives as Apoptosis Inducers with Potential Anticancer Effects

Structure-Activity Relationships of N-Methylthiolated Beta-Lactam Antibiotics with C-3 Substitutions and Their Selective Induction of Apoptosis in Human Cancer Cells

Design and Synthesis of New 2-Arylnaphthyridin-4-ones As Potent Antitumor Agents Targeting Tumorigenic Cell Lines

Anti-Proliferative Activity of Benzamide Analogs in A549 Tumor Cells in Vitro

Synthesis and Antitumor Activities of Novel Α-Aminophosphonate Derivatives Containing an Alizarin Moiety.